Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOHAMED H KHAN

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1649230988
CMS profile
120135
Location
REDDING, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$2,789.65

104 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,780.56 103
Education $9.09 1

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOHAMED H KHAN

NPI 1649230988 · CMS profile ID 120135

Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology

REDDING, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1649230988?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOHAMED H KHAN, NPI 1649230988, CMS profile ID 120135. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1649230988?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). MOHAMED H KHAN, NPI 1649230988, CMS profile ID 120135. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1649230988?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
MOHAMED H KHAN, NPI 1649230988, CMS profile ID 120135, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 104 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1649230988?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

104 matching records · $2,789.65 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 104 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 104.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $17.6806/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944452943 CMS
Boston Scientific Corporation $21.9206/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916649811 CMS
PFIZER INC. $18.2006/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949178895 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $89.4006/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 876375289 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.1006/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887502269 CMS
Kiniksa Pharmaceuticals, Ltd. $13.4906/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943843404 CMS
Abbott Laboratories $5.8206/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908683871 CMS
Abbott Laboratories $6.0006/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908683881 CMS
Abbott Laboratories $25.4506/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914244731 CMS
Actelion Pharmaceuticals US, Inc. $97.3305/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885375135 CMS
Merck Sharp & Dohme LLC $20.4005/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944485933 CMS
Novartis Pharmaceuticals Corporation $12.1605/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893829739 CMS
Terumo Medical Corporation $20.8305/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953086723 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.1805/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887502271 CMS
Novartis Pharmaceuticals Corporation $15.7305/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893829735 CMS
HeartFlow, Inc. $17.2505/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950327031 CMS
Abbott Laboratories $45.0105/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 910339717 CMS
Abbott Laboratories $7.7605/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914244735 CMS
Actelion Pharmaceuticals US, Inc. $21.3004/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885375137 CMS
CORDIS US CORP. $17.2204/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951944853 CMS
Bardy Diagnostics, Inc. $40.0004/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962545897 CMS
Abbott Laboratories $87.4904/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 910339719 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $120.8904/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887502279 CMS
Abbott Laboratories $19.9303/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920516267 CMS
AstraZeneca Pharmaceuticals LP $17.5103/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915158121 CMS
Janssen Pharmaceuticals, Inc $13.7603/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885815355 CMS
AstraZeneca Pharmaceuticals LP $22.9403/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915354937 CMS
PFIZER INC. $12.8203/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949075303 CMS
Boston Scientific Corporation $2.4103/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916649801 CMS
Boston Scientific Corporation $19.4403/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916649809 CMS
Actelion Pharmaceuticals US, Inc. $31.1703/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885375141 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.8303/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887502273 CMS
E.R. Squibb & Sons, L.L.C. $15.5003/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932592483 CMS
Boston Scientific Corporation $18.3403/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916649805 CMS
Abbott Laboratories $15.4103/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914244741 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6.2203/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887502275 CMS
Cardiovascular Systems Inc. $24.2103/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 947927121 CMS
Merck Sharp & Dohme LLC $19.5703/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944460868 CMS
E.R. Squibb & Sons, L.L.C. $4.4103/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932592481 CMS
Amgen Inc. $19.9702/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939415843 CMS
Novartis Pharmaceuticals Corporation $8.4202/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893829743 CMS
AstraZeneca Pharmaceuticals LP $18.4202/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914704679 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.0402/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887502277 CMS
Abbott Laboratories $1.6802/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920547547 CMS
Novartis Pharmaceuticals Corporation $12.8302/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893829731 CMS
Merck Sharp & Dohme LLC $17.3701/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944458213 CMS
Amgen Inc. $20.0001/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939415841 CMS
Novartis Pharmaceuticals Corporation $9.3101/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893829727 CMS
BOSTON SCIENTIFIC CORPORATION $9.4801/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893704391 CMS
Abbott Laboratories $44.1201/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920516247 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,457.99 115
PY2020 $1,438.08 75
PY2021 $2,305.40 93
PY2022 $2,789.65 104
PY2023 $17,666.04 85
PY2024 $34,716.94 98
PY2025 $24,495.50 80

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $336,085.38 20
PY2024 Principal investigator $62,974.00 16
PY2023 Principal investigator $45,012.00 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $12,074.00 12/15/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282724
Principal investigator 1 Janssen Research & Development, LLC $2,258.00 11/21/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281552
Principal investigator 1 Janssen Research & Development, LLC $8,160.00 10/22/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282414
Principal investigator 1 Janssen Research & Development, LLC $465.00 10/09/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281539
Principal investigator 1 Janssen Research & Development, LLC $1,986.00 09/19/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281711
Principal investigator 1 Janssen Research & Development, LLC $1,085.00 09/03/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282473
Principal investigator 1 Janssen Research & Development, LLC $8,027.00 08/25/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281751
Principal investigator 1 AstraZeneca Pharmaceuticals LP $41,201.20 08/07/2025 Non-covered Recipient Entity
BIOPHARMA INFORMATIC INC. DBA RESEARCH CONSULTANTS
A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function No dispute reported 06/30/2026 1185550365
Principal investigator 1 Amgen Inc. $194,669.70 08/01/2025 Non-covered Recipient Entity
BIOPHARMA INFORMATIC INC
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity No dispute reported 06/30/2026 1246639687
Principal investigator 1 Janssen Research & Development, LLC $3,955.00 07/23/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282738
Principal investigator 1 Amgen Inc. $27,843.48 07/20/2025 Non-covered Recipient Entity
BIOPHARMA INFORMATIC - THE CARDIOVASCULAR CENTER
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity No dispute reported 06/30/2026 1246639651
Principal investigator 1 Janssen Research & Development, LLC $310.00 06/26/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281497
Principal investigator 1 Janssen Research & Development, LLC $610.00 06/25/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281796
Principal investigator 1 Janssen Research & Development, LLC $1,927.00 06/20/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282245
Principal investigator 1 Janssen Research & Development, LLC $310.00 05/23/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175281790
Principal investigator 1 Janssen Research & Development, LLC $5,826.00 05/16/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282347
Principal investigator 1 Janssen Research & Development, LLC $3,115.00 04/23/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282128
Principal investigator 1 Janssen Research & Development, LLC $6,880.00 03/17/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282710
Principal investigator 1 Janssen Research & Development, LLC $13,397.00 02/24/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282393
Principal investigator 1 Janssen Research & Development, LLC $1,986.00 01/22/2025 Non-covered Recipient Entity
Biopharma Informatic
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175282070